REO / Bank Owned Short sales Residential sales Luxury homes First time home buyers Distressed properties Horse properties Probate Staging Relocation Property Management TIC Co-op
Work:
East Coast Realtors Inc. New York, NY (646)6204856 (Phone) License #10401222542
Client type:
Home Buyers Home Sellers
Property type:
Single Family Home Condo/Townhome Multi-family TIC Co-op
Awards:
Top Salesperson of 2011 Top Sales Team of 2012 Top Sales Team of 2013
Languages:
English Mandarin
Skills:
Selling at a possibly highest price in shortest period of time
Peter RICCIO - New Rochelle NY, US Tarun BHAMBHANI - Stamford CT, US Alan S. ROTHENBERG - Wilton CT, US Carmina QUINTANAR - Santiago, CL Bing WANG - Brookfield CT, US
Assignee:
CYTEC TECHNOLOGY CORP. - Wilmington DE
International Classification:
B03D 1/012 B03D 1/014 B03D 1/02
US Classification:
209166, 252 61
Abstract:
Formulations for value mineral collector compositions composed of at least one first collector selected from an organic ammonium salt of an organic sulfur-containing acid; and at least one second collector selected from neutral collectors and/or organic ammonium salts of an organic sulfur-containing acids, such that the second collector is different from said first collector, are provided herein, along with methods for making and using same.
Peter RICCIO - New Rochelle NY, US Tarun BHAMBHANI - Stamford CT, US Alan S. ROTHENBERG - Wilton CT, US Carmina QUINTANAR - Santiago, CL Bing WANG - Brookfield CT, US
Assignee:
CYTEC TECHNOLOGY CORP. - Wilmington DE
International Classification:
B03D 1/02
US Classification:
209166
Abstract:
Froth flotation processes that include adding a beneficiating amount of a value mineral collector composed of an organic ammonium salt of a sulfur-containing acid to at least one stage of a froth flotation process to recover value minerals from mineral ore bodies are disclosed herein.
Peter RICCIO - New Rochelle NY, US Tarun BHAMBHANI - Stamford CT, US Alan S. ROTHENBERG - Wilton CT, US Carmina QUINTANAR - Santiago, CL Bing WANG - Brookfield CT, US
Assignee:
CYTEC TECHNOLOGY CORP. - Wilmington DE
International Classification:
B03D 1/02 B03D 1/012
US Classification:
209166
Abstract:
Froth flotation processes that include adding a beneficiating amount of a value mineral collector composed of an organic ammonium salt of a sulfur-containing acid to at least one stage of a froth flotation process to recover value minerals from mineral ore bodies are disclosed herein.
Methods For Treating Chronic Obstructive Pulmonary Disease Using Benralizumab
- Södertälje, SE Christine Ward - Gaithersburg MD, US Ubaldo Martin - Gaithersburg MD, US Lorin Roskos - Gaithersburg MD, US Bing Wang - Gaithersburg MD, US
International Classification:
C07K 16/28 A61P 11/00
Abstract:
Provided herein is are methods of treating Chronic Obstructive Pulmonary Disease (COPD) in a patient, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof.
Methods For Treating Chronic Obstructive Pulmonary Disease Using Benralizumab
- Sodertalje, SE Christine Ward - Gaithersburg MD, US Ubaldo Martin - Gaithersburg MD, US Lorin Roskos - Gaithersburg MD, US Bing Wang - Gaithersburg MD, US
International Classification:
C07K 16/28 A61K 39/00
Abstract:
Provided herein is are methods of treating Chronic Obstructive Pulmonary Disease (COPD) in a patient, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof.
Methods For Reducing Exacerbation Rates Of Asthma Using Benralizumab
- SÖDERTÄLJE, SE Lorin Roskos - Gaithersburg MD, US Bing Wang - Gaithersburg MD, US Donald Raible - Berwyn PA, US
International Classification:
C07K 16/28
Abstract:
Provided herein is are methods of reducing exacerbations of asthma in an asthma patient, comprising administering to the patient an effective amount of the anti-interleukin-5 receptor (IL-5R) antibody benralizumab or an antigen-binding fragment thereof.
Methods For Treating Chronic Obstructive Pulmonary Disease Using Benralizumab
- Gaithersburg MD, US Christine Ward - Gaithersburg MD, US Ubaldo Martin - Gaithersburg MD, US Lorin Roskos - Gaithersburg MD, US Bing Wang - Gaithersburg MD, US
International Classification:
C07K 16/28
Abstract:
Provided herein is are methods of treating Chronic Obstructive Pulmonary Disease (COPD) in a patient, comprising administering to the patient an effective amount of benralizumab or an antigen-binding fragment thereof.
Fixed Dosage Regimens For Anti-Type I Interferon Receptor (Ifnar) Antibodies
- Gaithersburg MD, US Yihong Yao - Gaithersburg MD, US Bing Wang - Gaithersburg MD, US Lorin Roskos - Gaithersburg MD, US Linda Chang - Gaithersburg MD, US
Assignee:
Medlmmune, LLC - Gaithersburg MD
International Classification:
C07K 16/28 G06N 7/00 G06F 19/00 C12Q 1/68
Abstract:
The disclosure provides methods for treating a subject having a type I IFN-mediated disease or disorder comprising administration of a fixed does of an anti-interferon alpha receptor antibody. The disclosure also provides methods for suppressing a type I interferon (IFN) gene signature (GS) in a subject. In addition, the disclosure provides methods of prognosing or monitoring disease progression in a subject having a type I IFN-mediated disease or disorder, methods of predicting a dosage regimen, methods of identifying a candidate therapeutic agent, methods of identifying a patient as a candidate for a therapeutic agent, and methods of designating a personalized therapy.
2013 to 2014 Research AssistantChemical Engineering Department of NJIT
2012 to 2014 Lecturer in Chemical Engineering Department of NJITMerck Company
2011 to 2013 Research AssistantState Key Laboratory of Tianjin University
2008 to 2010 Research Assistant
Education:
New Jersey Institute of Technology Newark, NJ 2010 to 2015 PhD in Chemical EngineeringTianjin University Jun 2010 M.E. Chemical EngineeringTianjin University Jun 2004 B.S. in Applied Chemistry
Skills:
ANSYS-FLUENT & GAMBIT, AUTOCAD, SOLIDWORKS, ASPEN, FLOW 3D, FORTRAN, C++, MATLAB, Tecplot, MS-Office; VOF model with Moving Mesh and also writing UDF, 3-D SRF model, 3-D MRF model and Quasi - Single Phase Model with UDF
Weill Medical College New York, NY 2003 to 2004 Postdoctoral Research AssociateWeill Medicall College New York, NY 1999 to 2001 Postdoctoral Research AssociateNational institute for the control of Pharmaceutical and Biological Products
1993 to 1995 Assistant ProfessorNational institute for the control of Pharmaceutical and Biological Products
1990 to 1995 Research Fellow
Education:
Robert Morris University 2011 to 2013 Master of Business AdministrationBeijing Medical University 1984 to 1990